AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New DNA test: prescription for genetic precision.(Clinical Rounds)

OB GYN News

| February 01, 2005 | Wendling, Patrice | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Food and Drug Administration approval of the first DNA microarray test will allow physicians to consider patient-specific genetic information before prescribing medications for a variety of conditions such as cardiac disease, psychiatric disease, and cancer.

The new test offers comprehensive analysis of the cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2C19 (CYP2C19) genes, and identifies the associated predictive phenotype (poor, intermediate, extensive, or ultra-rapid metabolizer). Variations can cause a patient to metabolize certain drugs more quickly or more slowly than average, or not at all.

"The use of this test should allow for more refined decision making in the deployment of a wide variety of drugs," Steven Gutman, M.D., director of the FDA's office of in vitro diagnostics, told this newspaper. "The psychiatric area is particularly rich with literature and with potential use. Those drugs are the stars of the show, but there are a wide variety of other drugs that may show similar impact.

Approval of the test "isn't the end of the story, but the first chapter in the journey toward personalized medicine," Dr. Gutman said. "People will be able to select drugs more carefully and in a way that meets the unique genetic, metabolic needs of the patient."

The AmpliChip Cytochrome P450 Genotyping Test made by Roche Molecular Systems Inc., Pleasanton, Calif., was approved for analysis of the CYP2D6 gene in late December and analysis of the CYP2C19 gene in early January. The test is available in Europe for analysis of both genes, at a cost of 400 euros. The cost for use of the test in the United States has not been determined, a Roche spokesperson said.

The test was cleared for use with the Affymetrix GeneChip Microarray Instrumentation System, manufactured by Affymetrix of Santa Clara, Calif.

A microarray is similar to a computer microchip, but instead of tiny circuits, the glass chip contains millions of DNA molecules. The DNA is extracted from a standard blood sample that must be sent to a ...

Related articles from newspapers, magazines, journals, and more
Food and Drug Administration licenses new AIDS test. (Acquired Immune...
Press release article from: PR Newswire December 13, 1988 700+ words
...The Food and Drug Administration today licensed...minute screening test for detecting...antibody detection tests cannot be performed...including a test with a fresh...more specific tests based on independent...The approved test kit will be manufactured...S. Food and ...
Food and Drug Administration approves HIV-2 test kit.
Press release article from: PR Newswire April 25, 1990 700+ words
...closely related, tests for the antibody...2 antibody ELISA tests be validated with Western blot tests. The manufacturer...validation. The test will be manufactured...Brown of the Food and Drug Administration, 301-443-3285...
Food and Drug Administration approves blood bank test for leukemia. (Human...
Press release article from: PR Newswire November 29, 1988 700+ words
FOOD AND DRUG ADMINISTRATION APPROVES BLOOD BANK TEST FOR LEUKEMIA WASHINGTON...PRNewswire/ -- The Food and Drug Administration today approved three tests for the detection of antibodies...repeatably reactive screening test on more than one donation...
U.S. Food and Drug Administration Clears Vermillion's OVA1™ Test to...
Newspaper article from: Cancer Weekly September 29, 2009 700+ words
...surgery. We believe this test will help drive more...clearance of OVA1, a test that represents an important...to offer FDA cleared tests for ovarian cancer in...to offering the OVA1 Test, Quest Diagnostics was...Surgery, U.S. Food and Drug Administration, Women's Health...
Food and Drug Administration seeks to test blood testers.
Press release article from: PR Newswire June 5, 1989 700+ words
FOOD AND DRUG ADMINISTRATION SEEKS TO TEST BLOOD TESTERS WASHINGTON, June 5 /PRNewswire/ -- The Food and Drug Administration, which requires blood banks to test for AIDS and hepatitis, today proposed that...
XDx's AlloMap Gene Expression Test Cleared by U.S. Food and Drug Administration...
Newspaper article from: Heart Disease Weekly September 14, 2008 700+ words
...AlloMap(R) The AlloMap Test is a noninvasive, quantitative...molecular diagnostic blood test that applies a mathematical...yields a single AlloMap Test score. This composite...gene expression-based tests for the monitoring of...Actions, U.S. Food and Drug Administration, XDx Inc. ...
Environmental Diagnostics submits new opiates test to the Food and Drug...
Press release article from: PR Newswire January 17, 1990 700+ words
...TO THE FOOD AND DRUG ADMINISTRATION AS THE MARKETING...SCREEN: OPIATES test to the U.S. Food and Drug Administration for pre-market...the new opiates test for detecting the...EDI drugs of abuse tests." He added that...
FDA announces new meat test. (Food and Drug Administration, PR-TV) (NEWS...
Press release article from: PR Newswire January 4, 1988 700+ words
...standards define the test that must be submitted...carcinogenicity when fed to test animals. The final regulation...of Agriculture and FDA test animals and food products...additives. In thousands of tests each year, they randomly...Cruzan of the Food and Drug Administration, ...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA